Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer

EMSY, a BRCA2–associated protein, is amplified and overexpressed in various sporadic cancers. This is the first study assessing the clinical impact of its expression and polymorphisms on ovarian cancer (OvCa) outcome in the context of the chemotherapy regimen used. In 134 frozen OvCa samples, we ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Dansonka-Mieszkowska, Agnieszka, Szafron, Lukasz M., Moes-Sosnowska, Joanna, Kulinczak, Mariusz, Balcerak, Anna, Konopka, Bozena, Kulesza, Magdalena, Budzilowska, Agnieszka, Lukasik, Martyna, Piekarska, Urszula, Rzepecka, Iwona K., Parada, Joanna, Zub, Renata, Pienkowska-Grela, Barbara, Madry, Radoslaw, Siwicki, Jan K., Kupryjanczyk, Jolanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915152/
https://www.ncbi.nlm.nih.gov/pubmed/29707144
http://dx.doi.org/10.18632/oncotarget.24878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915152/
https://www.ncbi.nlm.nih.gov/pubmed/29707144
http://dx.doi.org/10.18632/oncotarget.24878

Ejemplares similares